Investment Summary

Schooner Capital Invests In SRS Medical

On May 1, 2012, private equity firm Schooner Capital invested in medical products company SRS Medical

Investment Highlights
  • This is Schooner Capital’s 2nd transaction in the Medical Products sector.
  • This is Schooner Capital’s 4th transaction in the United States.
  • This is Schooner Capital’s 3rd transaction in Massachusetts.

Investment Summary

Date 2012-05-01
Target SRS Medical
Sector Medical Products
Investor(s) Schooner Capital
Deal Type Venture

Target

SRS Medical

Chelmsford, Massachusetts, United States
SRS Medical provides urologic care with simple, proven technologies that use bladder function to actively manage clinical pathways for men with Benign Prostate Hyperplasia (BPH). SRS Medical was founded in 1991 and is based in Chelmsford, Massachusetts.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Schooner Capital

Boston, Massachusetts, United States

Category Private Equity Firm
Founded 1971
Size Small
Type Sector Agnostic
DESCRIPTION

Schooner Capital is a private investment firm and family office focused on direct company investments, as well as investing through independent managers. For direct company investments, Schooner invests across a variety of stages and sectors. The Firm is particularly attracted to businesses with 'recurring revenue, capital efficiency, and protective moats'. Schooner was formed in 1971 and is based in Boston, Massachusetts.


DEAL STATS #
Overall 4 of 8
Sector: Medical Products M&A 2 of 2
Type: Venture M&A Deals 1 of 3
State: Massachusetts M&A 3 of 6
Country: United States M&A 4 of 8
Year: 2012 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-02-01 Orthocare Innovations

Oklahoma City, Oklahoma, United States

Orthocare Innovations is an orthotics and prosthetics company developing advanced adaptive products that monitor, analyze, and react in real-time to changes in patient physiology, alignment, and gait.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-01-22 Topokine Therapeutics

Boston, Massachusetts, United States

Topokine Therapeutics, Inc. is a clinical-stage biotechnology company developing topical prescription medications to contour the face and body non-invasively.

Buy -